Enbrel has been used clinically for over 5 years and is currently FDA approved for psoriasis, rheumatoid arthritis, juvenile rheumatoid arthritis, and psoriatic arthritis.

To be included in the study, you must satisfy the following criteria:
1. 18 years of age or older
2. Have psoriasis involving greater than or equal to 10% of your body
3. Are not pregnant (women)
4. No history of insulin dependent diabetes, congestive heart failure, heart attack, severe angina pectoris, uncontrolled hypertension, severe pulmonary disease requiring oxygen therapy, multiple sclerosis, hepatitis, systemic lupus erythematosis, HIV, or tuberculosis

If you feel you qualify and are interested in participating or learning more about this exciting study, please contact us.

If you feel that you may not qualify but are interested in pursuing treatment for your psoriasis, our office offers cutting edge treatment for both localized and generalized psoraisis including narrow band ultraviolet light therapy and excimer laser therapy with the Xtrac laser. If you are interested contact us for an appointment.